person · Reporting owner
SOBECKI CHRISTOPHER J
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,177 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 293,177 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WW INTERNATIONAL, INC.
Report date May 31, 2023 · Filed May 31, 2023
Section 16 reporting ended · disclosed 2023-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,954 |
Ending reported balance
After 2023-05-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-31 · Grant · Acquired 1,353 · Balance 107,901 Row 2 · 2023-05-31 · Exercise / conversion · Acquired 2,053 · Balance 109,954 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-31 · Exercise / conversion · Disposed 2,053 · Balance 0 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.
F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 791 | $2.60 | $2,056.60 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 24 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,115 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 200 | $2.59 | $518.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 23 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,324 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 900 | $2.57 | $2,313.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 22 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,124 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.58 | $258.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 21 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,224 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 900 | $2.56 | $2,304.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 20 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,124 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 800 | $2.54 | $2,032.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 19 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,224 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 400 | $2.55 | $1,020.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 18 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,424 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 820 | $2.53 | $2,074.60 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 17 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,024 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,405 | $2.52 | $3,540.60 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 16 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,204 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.53 | $252.50 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 15 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,799 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.54 | $253.50 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 14 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,699 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,151 | $2.50 | $2,877.50 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 13 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,599 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 3,300 | $2.48 | $8,184.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 12 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,448 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,500 | $2.47 | $6,175.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 11 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,148 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 200 | $2.45 | $490.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 10 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,648 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,400 | $2.46 | $3,444.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 9 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,448 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,784 | $2.49 | $4,442.16 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 8 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,048 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.49 | $248.50 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 7 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,264 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 776 | $2.51 | $1,947.76 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 6 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,164 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 295 | $2.52 | $741.93 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 5 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,388 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 500 | $2.43 | $1,215.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 4 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,093 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 300 | $2.41 | $723.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 3 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,593 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 800 | $2.40 | $1,920.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,293 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 200 | $2.38 | $476.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,493 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 300 | $2.48 | $744.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 28 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,293 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.48 | $247.75 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 27 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,993 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 3,336 | $2.47 | $8,239.92 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 26 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,893 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 100 | $2.47 | $246.50 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 25 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,557 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 5,200 | $2.46 | $12,792.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 24 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,457 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,400 | $2.45 | $5,880.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 23 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,257 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 15,158 | $2.44 | $36,985.52 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 22 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,857 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 400 | $2.44 | $974.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 21 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,699 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 5,225 | $2.43 | $12,696.75 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 20 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,299 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 9,943 | $2.42 | $24,062.06 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 19 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,074 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,000 | $2.42 | $2,415.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 18 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,131 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 8,112 | $2.41 | $19,549.92 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 17 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,131 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 200 | $2.41 | $481.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 16 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,019 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 9,450 | $2.40 | $22,680.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 15 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,819 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 14,338 | $2.39 | $34,267.82 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 14 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,369 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,396 | $2.39 | $3,329.46 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 13 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,031 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 9,784 | $2.38 | $23,285.92 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 12 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,635 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,206 | $2.37 | $5,228.22 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 11 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,851 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,200 | $2.36 | $2,832.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 10 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,645 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 600 | $2.35 | $1,410.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 9 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,445 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 3,500 | $2.34 | $8,190.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 8 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,845 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,000 | $2.33 | $2,330.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 7 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,345 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,000 | $2.32 | $2,320.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 6 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,345 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,600 | $2.31 | $3,696.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 5 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,345 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 400 | $2.30 | $920.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 4 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,745 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 500 | $2.28 | $1,140.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 3 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,345 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.